SlideShare a Scribd company logo
1 of 50
Foundations in Microbiology
Chapter
12
PowerPoint to accompany
Fifth Edition
Talaro
Copyright The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
2
Drugs, Microbes, Host – The
Elements of Chemotherapy
Chapter 12
3
4
5
Origins of antimicrobial drugs
• Antibiotics are common metabolic products of
aerobic spore-forming bacteria & fungi.
– bacteria in genera Streptomyces & Bacillus
– molds in genera Penicillium & Cephalosporium
• By inhibiting the other microbes in the same
habitat, antibiotic producers have less
competition for nutrients & space.
6
Selectively toxic
• Drugs should kill or inhibit microbial cells
without simultaneously damaging host
tissues.
• As the characteristics of the infectious agent
become more similar to the vertebrate host
cell, complete selective toxicity becomes
more difficult to achieve & more side
effects are seen.
7
Targets of antimicrobial drugs
1. Inhibition of cell wall synthesis
2. Inhibition of nucleic acid synthesis,
structure or function
3. Inhibition of protein synthesis
4. Disruption of cell membrane structure or
function
8
Targets of antimicrobial drugs
9
1. Drugs that affect the bacterial cell
wall
• Most bacterial cell walls contain a rigid girdle of
peptidoglycan.
• Penicillin and cephalosporin block synthesis of
peptidoglycan, causing the cell wall to lyse.
• Penicillins do not penetrate the outer membrane and
are less effective against gram-negative bacteria.
• Broad spectrum penicillins and cephalosporins can
cross the cell walls of gram-negative bacteria.
10
1. Drugs that affect the bacterial cell
wall
11
1. Drugs that affect the bacterial cell
wall
12
2. Drugs that inhibit nucleic acid
synthesis
• may block synthesis of nucleotides, inhibit
replication, or stop transcription
• Sulfonamides and trimethoprim block enzymes
required for tetrahydrofolate synthesis needed
for DNA & RNA synthesis.
• competitive inhibition – drug competes with
normal substrate for enzyme’s active site
• synergistic effect – an additive effect,
achieved by multiple drugs working together,
requiring a lower dose of each
13
2. Drugs that inhibit nucleic acid
synthesis
14
3. Drugs that block protein synthesis
• Ribosomes of eucaryotes differ in size and
structure from procaryotes, so antimicrobics
usually have a selective action against
procaryotes. But they can also damage the
eucaryotic mitochondria.
• Aminoglycosides (streptomycin, gentamicin)
insert on sites on the 30S subunit and cause
misreading of mRNA.
• Tetracyclines block attachment of tRNA on
the A acceptor site and stop further synthesis.
15
3. Drugs that block protein synthesis
16
4. Drugs that disrupt cell membrane
function
• A cell with a damaged membrane dies from
disruption in metabolism or lysis.
• These drugs have specificity for a particular
microbial group, based on differences in types
of lipids in their cell membranes.
• Polymyxins interact with phospholipids and
cause leakage, particularly in gram-negative
bacteria
• Amphotericin B and nystatin form complexes
with sterols on fungal membranes which
causes leakage.
17
4. Drugs that disrupt cell membrane
function
18
Survey of major antimicrobial drug
groups
• Antibacterial drugs
– Antibiotics
– Synthetic drugs
• Antifungal drugs
• Antiparasitic drugs
• Antiviral drugs
About 260 different antimicrobial drugs are
classified in 20 drug families.
19
Antibacterial antibiotics
• Penicillins
• Cephalosporins
• Other beta-lactam antibiotics
• Aminoglycosides
• Tetracycline antibiotics
• Chloramphenicol
• Other Streptomyces antibiotics
• The Bacillus antibiotics
• New classes
20
Penicillins
• Large diverse group of compounds
• Could be synthesized in the laboratory
• more economical to obtain natural penicillin
through microbial fermentation and modify it to
semi-synthetic forms
• Penicillium chrysogenum – major source
• All consist of 3 parts
– thiazolidine ring
– beta-lactam ring
– variable side chain dictates microbial activity
21
Penicillins
22
Penicillins
• Penicillins G and V most important natural forms
• Penicillin is the drug of choice for gram-positive
cocci (streptococci) and some gram-negative
bacteria (meningococci and syphilis spirochete)
• Semisynthetic penicillins – ampicillin,
carbenicillin & amoxicillin have broader spectra –
gram negative enterics rods
• Penicillinase-resistant – methicillin, nafcillin,
cloxacillin
• Primary problems – allergies and resistant strains
of bacteria
23
Cephalosporins
• Account for majority of all antibiotics
administered
• Isolated from Cephalosporium acremonium mold
• Beta-lactam ring that can be altered
• Relatively broad-spectrum, resistant to most
penicillinases, & cause fewer allergic reactions
• Some are given orally, many must be administered
parenterally
24
Cephalosporins
25
Cephalosporins
• 3 generations exist
• First generation – cephalothin, cefazolin – most
effective against gram-positive cocci
• Second generation – cefaclor, cefonacid – more
effective against gram-negative bacteria
• Third generation – cephalexin, cefotaxime – broad-
spectrum activity against enteric bacteria with beta-
lactamases
• Ceftriaxone – new semisynthetic broad-spectrum drug
for treating wide variety of infections
26
Other beta-lactam antibiotics
• Imipenem – broad-spectrum drug for
infections with aerobic and anaerobic
pathogens
• Azeotreonam –isolated from bacteria
Chromobacterium violaceum – newer
narrow-spectrum drug for infections by
gram-negative aerobic bacilli. May be used
by people allergic to penicillin.
27
Aminoglycosides
• composed of 2 or more amino sugars and an
aminocyclitol (6C) ring
• products of various species of soil actinomycetes in
genera Streptomyces & Micromonospora
• Broad-spectrum, inhibit protein synthesis, especially
useful against aerobic gram-negative rods & certain
gram-positive bacteria
– Streptomycin – bubonic plague, tularemia, TB
– Gentamicin – less toxic, used against gram-negative rods
– Newer – Tobramycin & amikacin gram-negative bacteria
28
Aminoglycosides
29
Tetracycline antibiotics
• Broad-spectrum, block protein synthesis
• Doxycycline & minocycline – oral drugs
taken for STDs, Rocky Mountain spotted
fever, Lyme disease, typhus, acne &
protozoa
30
Chloramphenicol
• Isolated from Streptomyces venezuelae
• Potent broad-spectrum drug with unique
nitrobenzene structure
• Blocks peptide bond formation
• No longer derived from natural source
• Very toxic, restricted uses, can cause irreversible
damage to bone marrow
• Typhoid fever, brain abscesses, rickettsial &
chlamydial infections
31
32
Other Streptomyces antibiotics
• Erythromycin – macrolide, large lactone ring with
sugars
• Broad-spectrum, fairly low toxicity
• Attaches to ribosome
• Taken orally for Mycoplasma pneumonia,
legionellosis, Chlamydia, pertussis, diptheria and
as a prophylactic prior to intestinal surgery
• For penicillin-resistant – gonococci, syphilis, acne
• Newer semi-synthetic macrolides – clarithomycin,
azithromycin
33
Other Streptomyces antibiotics
• Clindamycin – broad-spectrum, serious
abdominal anaerobic infections
• Vancomycin –narrow-spectrum, effective
against penicillin & methicillin resistant
staphylococcal infections; very toxic, hard to
administer
• Rifampin – limited spectrum, cannot pause
through many cell membranes, used to treat
gram-positive bacteria, TB, leprosy
34
The Bacillus antibiotics
• Bacitracin- narrow-spectrum peptide
produce by Bacillus subtilis, major
ingredient of neosporin ointment
• Polymyxin - narrow-spectrum peptide with
fatty acid component, detergent activity;
limited by toxicity to kidney; drug resistant
Pseudomonas aeruginosa & UTI
35
New classes of antibiotics
• Fosfomycin trimethamine – a phosporic
acid effective as alternate treatment for
UTIs, inhibits cell wall synthesis
• Synercid – effective against Staphylococcus
& Enterococcus that cause endocarditis &
surgical infections; inhibits protein
synthesis
36
Synthetic antibacterial drugs
• Sulfonamides, sulfa drugs – first
antimicrobic drugs
• Sulfisoxazole – shigellosis, UTI, protozoan
infections
• Silver sulfadiazine –burns, eye infections
• Trimethoprim – given in combination with
sulfamethoxazole – UTI, PCP
37
Sulfonamides
38
Miscellaneous antibacterial drugs
• Isoniazid –used with rifampicin to treat TB
• Oxazolidinones- new class of antibacterial drugs
inhibit initiation of protein synthesis
– Linezolid – MRSA, VRE
• Fluoroquinolones –broad-spectrum, potent
– norfloxacin, ciprofloxacin – UTI, STD, GI,
osteomyletitis, respiratory & soft tissue infections
– sparofloxacin, levofloxacin – pneumonia, bronchitis,
sinusitis
39
Antifungal drugs
• Macrolide polyene
– Amphotericin B –mimic lipids, most versatile &
effective, topical & systemic treatments
– Nystatin – topical treatment
• Griseofulvin – stubborn cases of dermatophyte
infections, nephrotoxic
• Synthetic azoles – broad-spectrum; ketoconazole,
clotrimazole, miconazole
• Flucytosine – analog of cytosine; cutaneous
mycoses or in combination with amphotericin B
for systemic mycoses
40
Antifungal drugs
41
Antiparasitic drugs
• Antimalarial drugs – quinine, chloroquinine,
primaquine, mefloquine
• Antiprotozoan drugs - Metronidazole (Flagyl),
quinicrine, sulfonamides, tetracyclines
• Antihelminthic drugs – immobilize, disintegrate,
or inhibit metabolism
– mebendazole, thiabendazole- broad-spectrum – inhibit
function of microtubules, interfers with glucose
utilization & disables them
– pyrantel, piperazine- paralyze muscles
– niclosamide – destroys scolex
42
Antiviral drugs
• Block penetration into host cell
• Block transcription or translation
– Nucleotide analogs
• Acyclovir – herpesviruses
• Ribavirin- a guanine analog – RSV, hemorrhagic fevers
• AZT – thymine analog - HIV
• Prevent maturation of viral particles
– Protease inhibitors – HIV
• Interferon - HCV
43
Mechanisms drug resistance
• Drug inactivation – penicillinases
• Decreased permeability to drug or increased
elimination of drug from cell
• Change in metabolic patterns
• Change in drug receptors
44
Mechanisms drug resistance
45
Selection for drug resistance
46
Side effects of drugs
1. Toxicity to organs
2. Allergic responses
3. Suppression and alteration of microflora
47
48
49
Considerations in selecting an
antimicrobial drug
1. nature of microbe causing infection
2. degree of microbe’s sensitivity to various
drugs
3. overall medical condition of patient
50
• Minimum inhibitory concentration (MIC)-
smallest concentration of drug that visibly
inhibits growth
• Therapeutic index – the ratio of the dose of
the drug that is toxic to humans as
compared to its minimum effective dose

More Related Content

What's hot

What's hot (18)

Introduction to chemotherapy
Introduction to chemotherapyIntroduction to chemotherapy
Introduction to chemotherapy
 
Antimicrobials
AntimicrobialsAntimicrobials
Antimicrobials
 
Antibiotic (asif) nsupharmacy
Antibiotic (asif) nsupharmacyAntibiotic (asif) nsupharmacy
Antibiotic (asif) nsupharmacy
 
2.ANTIBIOTIC (CELL WALL INHIBITORS)
2.ANTIBIOTIC (CELL WALL INHIBITORS)2.ANTIBIOTIC (CELL WALL INHIBITORS)
2.ANTIBIOTIC (CELL WALL INHIBITORS)
 
Antibiotics
Antibiotics Antibiotics
Antibiotics
 
Class broad spectrum antibiotics
Class broad spectrum antibioticsClass broad spectrum antibiotics
Class broad spectrum antibiotics
 
Anti Biotics
Anti BioticsAnti Biotics
Anti Biotics
 
Betalactum antibiotics
Betalactum antibioticsBetalactum antibiotics
Betalactum antibiotics
 
Introduction to antimicrobials
Introduction to antimicrobialsIntroduction to antimicrobials
Introduction to antimicrobials
 
Antimicrobials General consideration
Antimicrobials General considerationAntimicrobials General consideration
Antimicrobials General consideration
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Chemotherapy
ChemotherapyChemotherapy
Chemotherapy
 
Antimicrobial agents 1 wafaa
Antimicrobial agents 1 wafaaAntimicrobial agents 1 wafaa
Antimicrobial agents 1 wafaa
 
Principles of antimicrobial therapy - Pharmacology
Principles of antimicrobial therapy - PharmacologyPrinciples of antimicrobial therapy - Pharmacology
Principles of antimicrobial therapy - Pharmacology
 
Antibiotic
Antibiotic Antibiotic
Antibiotic
 
Pharmacology of Antibiotics
Pharmacology of AntibioticsPharmacology of Antibiotics
Pharmacology of Antibiotics
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Antibacterial agents(1)
Antibacterial agents(1)Antibacterial agents(1)
Antibacterial agents(1)
 

Similar to Drugs microbes-host315

Lecture 6 protein synthesis inhibiting antibiotics
Lecture 6 protein synthesis inhibiting antibioticsLecture 6 protein synthesis inhibiting antibiotics
Lecture 6 protein synthesis inhibiting antibioticsana munir
 
m4_hg_antibiotics (1).ppt
m4_hg_antibiotics (1).pptm4_hg_antibiotics (1).ppt
m4_hg_antibiotics (1).pptAnarghaNambiar
 
Antibiotics classification ppt
Antibiotics classification pptAntibiotics classification ppt
Antibiotics classification pptajengsekarkirana
 
Antibiotics-a detailed classification | a detailed pharmacological study
Antibiotics-a detailed classification | a detailed pharmacological study Antibiotics-a detailed classification | a detailed pharmacological study
Antibiotics-a detailed classification | a detailed pharmacological study martinshaji
 
Pharmacology of Antibiotics
Pharmacology of  AntibioticsPharmacology of  Antibiotics
Pharmacology of AntibioticsAmr Rafat
 
MACROLIDE ANTIBIOTICS.pptx
MACROLIDE ANTIBIOTICS.pptxMACROLIDE ANTIBIOTICS.pptx
MACROLIDE ANTIBIOTICS.pptxRushikeshTidake
 
Antibiotics in pediatric dentistry
Antibiotics in pediatric dentistryAntibiotics in pediatric dentistry
Antibiotics in pediatric dentistryShubham Gupta
 
Antibiotics 150406092448-conversion-gate01
Antibiotics 150406092448-conversion-gate01Antibiotics 150406092448-conversion-gate01
Antibiotics 150406092448-conversion-gate01Mostafa Abd El Fattah
 
Chemotherapy FOR Pharmacy Lab.Students.pptx
Chemotherapy FOR Pharmacy Lab.Students.pptxChemotherapy FOR Pharmacy Lab.Students.pptx
Chemotherapy FOR Pharmacy Lab.Students.pptxebulcha100
 
Antibiotics lecture may 2010
Antibiotics lecture may 2010Antibiotics lecture may 2010
Antibiotics lecture may 2010Bruno Mmassy
 
Antibiotics by DR: ABBAS ALI SHAH
Antibiotics by DR: ABBAS ALI SHAH Antibiotics by DR: ABBAS ALI SHAH
Antibiotics by DR: ABBAS ALI SHAH AjazAttari1
 
ANTIBIOTICS IN ORAL & MAXILLOFACIAL SURGERY
ANTIBIOTICS IN ORAL & MAXILLOFACIAL SURGERYANTIBIOTICS IN ORAL & MAXILLOFACIAL SURGERY
ANTIBIOTICS IN ORAL & MAXILLOFACIAL SURGERYankitaraj63
 
antimicrobialchemotheray.pdf
antimicrobialchemotheray.pdfantimicrobialchemotheray.pdf
antimicrobialchemotheray.pdfOgunsina1
 

Similar to Drugs microbes-host315 (20)

Lecture 6 protein synthesis inhibiting antibiotics
Lecture 6 protein synthesis inhibiting antibioticsLecture 6 protein synthesis inhibiting antibiotics
Lecture 6 protein synthesis inhibiting antibiotics
 
8. Antimikroba_10.ppt
8. Antimikroba_10.ppt8. Antimikroba_10.ppt
8. Antimikroba_10.ppt
 
m4_hg_antibiotics (1).ppt
m4_hg_antibiotics (1).pptm4_hg_antibiotics (1).ppt
m4_hg_antibiotics (1).ppt
 
ANTIBIOTICS.ppt
ANTIBIOTICS.pptANTIBIOTICS.ppt
ANTIBIOTICS.ppt
 
Antimicrobials.ppt
Antimicrobials.pptAntimicrobials.ppt
Antimicrobials.ppt
 
Antibiotics classification ppt
Antibiotics classification pptAntibiotics classification ppt
Antibiotics classification ppt
 
Antibiotics-a detailed classification | a detailed pharmacological study
Antibiotics-a detailed classification | a detailed pharmacological study Antibiotics-a detailed classification | a detailed pharmacological study
Antibiotics-a detailed classification | a detailed pharmacological study
 
Pharmacology of Antibiotics
Pharmacology of  AntibioticsPharmacology of  Antibiotics
Pharmacology of Antibiotics
 
MACROLIDE ANTIBIOTICS.pptx
MACROLIDE ANTIBIOTICS.pptxMACROLIDE ANTIBIOTICS.pptx
MACROLIDE ANTIBIOTICS.pptx
 
Antibiotics in pediatric dentistry
Antibiotics in pediatric dentistryAntibiotics in pediatric dentistry
Antibiotics in pediatric dentistry
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Antibiotics 150406092448-conversion-gate01
Antibiotics 150406092448-conversion-gate01Antibiotics 150406092448-conversion-gate01
Antibiotics 150406092448-conversion-gate01
 
1.sulfonamide final
1.sulfonamide final1.sulfonamide final
1.sulfonamide final
 
Chemotherapy FOR Pharmacy Lab.Students.pptx
Chemotherapy FOR Pharmacy Lab.Students.pptxChemotherapy FOR Pharmacy Lab.Students.pptx
Chemotherapy FOR Pharmacy Lab.Students.pptx
 
Antibiotics lecture may 2010
Antibiotics lecture may 2010Antibiotics lecture may 2010
Antibiotics lecture may 2010
 
Antibiotics by DR: ABBAS ALI SHAH
Antibiotics by DR: ABBAS ALI SHAH Antibiotics by DR: ABBAS ALI SHAH
Antibiotics by DR: ABBAS ALI SHAH
 
ANTIBIOTICS IN ORAL & MAXILLOFACIAL SURGERY
ANTIBIOTICS IN ORAL & MAXILLOFACIAL SURGERYANTIBIOTICS IN ORAL & MAXILLOFACIAL SURGERY
ANTIBIOTICS IN ORAL & MAXILLOFACIAL SURGERY
 
antimicrobialchemotheray.pdf
antimicrobialchemotheray.pdfantimicrobialchemotheray.pdf
antimicrobialchemotheray.pdf
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 

More from Cleophas Rwemera

Chapter003 150907175411-lva1-app6891
Chapter003 150907175411-lva1-app6891Chapter003 150907175411-lva1-app6891
Chapter003 150907175411-lva1-app6891Cleophas Rwemera
 
Chapter002 150831173907-lva1-app6892
Chapter002 150831173907-lva1-app6892Chapter002 150831173907-lva1-app6892
Chapter002 150831173907-lva1-app6892Cleophas Rwemera
 
Chapter001 150823230128-lva1-app6892
Chapter001 150823230128-lva1-app6892Chapter001 150823230128-lva1-app6892
Chapter001 150823230128-lva1-app6892Cleophas Rwemera
 
Chapter25 cancer-140105085413-phpapp01
Chapter25 cancer-140105085413-phpapp01Chapter25 cancer-140105085413-phpapp01
Chapter25 cancer-140105085413-phpapp01Cleophas Rwemera
 
Chapter24 immunology-140105101108-phpapp02
Chapter24 immunology-140105101108-phpapp02Chapter24 immunology-140105101108-phpapp02
Chapter24 immunology-140105101108-phpapp02Cleophas Rwemera
 
Chapter23 nervecells-140105100942-phpapp02
Chapter23 nervecells-140105100942-phpapp02Chapter23 nervecells-140105100942-phpapp02
Chapter23 nervecells-140105100942-phpapp02Cleophas Rwemera
 
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02Cleophas Rwemera
 
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02Chapter21 cellbirthlineageanddeath-140105095914-phpapp02
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02Cleophas Rwemera
 
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01Cleophas Rwemera
 
Chapter19 integratingcellsintotissues-140105095535-phpapp02
Chapter19 integratingcellsintotissues-140105095535-phpapp02Chapter19 integratingcellsintotissues-140105095535-phpapp02
Chapter19 integratingcellsintotissues-140105095535-phpapp02Cleophas Rwemera
 
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...Cleophas Rwemera
 
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02Cleophas Rwemera
 
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...Cleophas Rwemera
 
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...Cleophas Rwemera
 
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01Cleophas Rwemera
 
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01Cleophas Rwemera
 
Chapter12 cellularenergetics-140105093734-phpapp01
Chapter12 cellularenergetics-140105093734-phpapp01Chapter12 cellularenergetics-140105093734-phpapp01
Chapter12 cellularenergetics-140105093734-phpapp01Cleophas Rwemera
 
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02Cleophas Rwemera
 
Chapter10 biomembranestructure-140105093829-phpapp02
Chapter10 biomembranestructure-140105093829-phpapp02Chapter10 biomembranestructure-140105093829-phpapp02
Chapter10 biomembranestructure-140105093829-phpapp02Cleophas Rwemera
 
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01Cleophas Rwemera
 

More from Cleophas Rwemera (20)

Chapter003 150907175411-lva1-app6891
Chapter003 150907175411-lva1-app6891Chapter003 150907175411-lva1-app6891
Chapter003 150907175411-lva1-app6891
 
Chapter002 150831173907-lva1-app6892
Chapter002 150831173907-lva1-app6892Chapter002 150831173907-lva1-app6892
Chapter002 150831173907-lva1-app6892
 
Chapter001 150823230128-lva1-app6892
Chapter001 150823230128-lva1-app6892Chapter001 150823230128-lva1-app6892
Chapter001 150823230128-lva1-app6892
 
Chapter25 cancer-140105085413-phpapp01
Chapter25 cancer-140105085413-phpapp01Chapter25 cancer-140105085413-phpapp01
Chapter25 cancer-140105085413-phpapp01
 
Chapter24 immunology-140105101108-phpapp02
Chapter24 immunology-140105101108-phpapp02Chapter24 immunology-140105101108-phpapp02
Chapter24 immunology-140105101108-phpapp02
 
Chapter23 nervecells-140105100942-phpapp02
Chapter23 nervecells-140105100942-phpapp02Chapter23 nervecells-140105100942-phpapp02
Chapter23 nervecells-140105100942-phpapp02
 
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02
 
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02Chapter21 cellbirthlineageanddeath-140105095914-phpapp02
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02
 
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01
 
Chapter19 integratingcellsintotissues-140105095535-phpapp02
Chapter19 integratingcellsintotissues-140105095535-phpapp02Chapter19 integratingcellsintotissues-140105095535-phpapp02
Chapter19 integratingcellsintotissues-140105095535-phpapp02
 
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...
 
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02
 
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...
 
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...
 
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01
 
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01
 
Chapter12 cellularenergetics-140105093734-phpapp01
Chapter12 cellularenergetics-140105093734-phpapp01Chapter12 cellularenergetics-140105093734-phpapp01
Chapter12 cellularenergetics-140105093734-phpapp01
 
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02
 
Chapter10 biomembranestructure-140105093829-phpapp02
Chapter10 biomembranestructure-140105093829-phpapp02Chapter10 biomembranestructure-140105093829-phpapp02
Chapter10 biomembranestructure-140105093829-phpapp02
 
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01
 

Recently uploaded

The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Celine George
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfchloefrazer622
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsKarinaGenton
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxRoyAbrique
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991RKavithamani
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
Micromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of PowdersMicromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of PowdersChitralekhaTherkar
 
Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfUmakantAnnand
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxOH TEIK BIN
 

Recently uploaded (20)

The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its Characteristics
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Micromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of PowdersMicromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of Powders
 
Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.Compdf
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptx
 

Drugs microbes-host315

  • 1. Foundations in Microbiology Chapter 12 PowerPoint to accompany Fifth Edition Talaro Copyright The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
  • 2. 2 Drugs, Microbes, Host – The Elements of Chemotherapy Chapter 12
  • 3. 3
  • 4. 4
  • 5. 5 Origins of antimicrobial drugs • Antibiotics are common metabolic products of aerobic spore-forming bacteria & fungi. – bacteria in genera Streptomyces & Bacillus – molds in genera Penicillium & Cephalosporium • By inhibiting the other microbes in the same habitat, antibiotic producers have less competition for nutrients & space.
  • 6. 6 Selectively toxic • Drugs should kill or inhibit microbial cells without simultaneously damaging host tissues. • As the characteristics of the infectious agent become more similar to the vertebrate host cell, complete selective toxicity becomes more difficult to achieve & more side effects are seen.
  • 7. 7 Targets of antimicrobial drugs 1. Inhibition of cell wall synthesis 2. Inhibition of nucleic acid synthesis, structure or function 3. Inhibition of protein synthesis 4. Disruption of cell membrane structure or function
  • 9. 9 1. Drugs that affect the bacterial cell wall • Most bacterial cell walls contain a rigid girdle of peptidoglycan. • Penicillin and cephalosporin block synthesis of peptidoglycan, causing the cell wall to lyse. • Penicillins do not penetrate the outer membrane and are less effective against gram-negative bacteria. • Broad spectrum penicillins and cephalosporins can cross the cell walls of gram-negative bacteria.
  • 10. 10 1. Drugs that affect the bacterial cell wall
  • 11. 11 1. Drugs that affect the bacterial cell wall
  • 12. 12 2. Drugs that inhibit nucleic acid synthesis • may block synthesis of nucleotides, inhibit replication, or stop transcription • Sulfonamides and trimethoprim block enzymes required for tetrahydrofolate synthesis needed for DNA & RNA synthesis. • competitive inhibition – drug competes with normal substrate for enzyme’s active site • synergistic effect – an additive effect, achieved by multiple drugs working together, requiring a lower dose of each
  • 13. 13 2. Drugs that inhibit nucleic acid synthesis
  • 14. 14 3. Drugs that block protein synthesis • Ribosomes of eucaryotes differ in size and structure from procaryotes, so antimicrobics usually have a selective action against procaryotes. But they can also damage the eucaryotic mitochondria. • Aminoglycosides (streptomycin, gentamicin) insert on sites on the 30S subunit and cause misreading of mRNA. • Tetracyclines block attachment of tRNA on the A acceptor site and stop further synthesis.
  • 15. 15 3. Drugs that block protein synthesis
  • 16. 16 4. Drugs that disrupt cell membrane function • A cell with a damaged membrane dies from disruption in metabolism or lysis. • These drugs have specificity for a particular microbial group, based on differences in types of lipids in their cell membranes. • Polymyxins interact with phospholipids and cause leakage, particularly in gram-negative bacteria • Amphotericin B and nystatin form complexes with sterols on fungal membranes which causes leakage.
  • 17. 17 4. Drugs that disrupt cell membrane function
  • 18. 18 Survey of major antimicrobial drug groups • Antibacterial drugs – Antibiotics – Synthetic drugs • Antifungal drugs • Antiparasitic drugs • Antiviral drugs About 260 different antimicrobial drugs are classified in 20 drug families.
  • 19. 19 Antibacterial antibiotics • Penicillins • Cephalosporins • Other beta-lactam antibiotics • Aminoglycosides • Tetracycline antibiotics • Chloramphenicol • Other Streptomyces antibiotics • The Bacillus antibiotics • New classes
  • 20. 20 Penicillins • Large diverse group of compounds • Could be synthesized in the laboratory • more economical to obtain natural penicillin through microbial fermentation and modify it to semi-synthetic forms • Penicillium chrysogenum – major source • All consist of 3 parts – thiazolidine ring – beta-lactam ring – variable side chain dictates microbial activity
  • 22. 22 Penicillins • Penicillins G and V most important natural forms • Penicillin is the drug of choice for gram-positive cocci (streptococci) and some gram-negative bacteria (meningococci and syphilis spirochete) • Semisynthetic penicillins – ampicillin, carbenicillin & amoxicillin have broader spectra – gram negative enterics rods • Penicillinase-resistant – methicillin, nafcillin, cloxacillin • Primary problems – allergies and resistant strains of bacteria
  • 23. 23 Cephalosporins • Account for majority of all antibiotics administered • Isolated from Cephalosporium acremonium mold • Beta-lactam ring that can be altered • Relatively broad-spectrum, resistant to most penicillinases, & cause fewer allergic reactions • Some are given orally, many must be administered parenterally
  • 25. 25 Cephalosporins • 3 generations exist • First generation – cephalothin, cefazolin – most effective against gram-positive cocci • Second generation – cefaclor, cefonacid – more effective against gram-negative bacteria • Third generation – cephalexin, cefotaxime – broad- spectrum activity against enteric bacteria with beta- lactamases • Ceftriaxone – new semisynthetic broad-spectrum drug for treating wide variety of infections
  • 26. 26 Other beta-lactam antibiotics • Imipenem – broad-spectrum drug for infections with aerobic and anaerobic pathogens • Azeotreonam –isolated from bacteria Chromobacterium violaceum – newer narrow-spectrum drug for infections by gram-negative aerobic bacilli. May be used by people allergic to penicillin.
  • 27. 27 Aminoglycosides • composed of 2 or more amino sugars and an aminocyclitol (6C) ring • products of various species of soil actinomycetes in genera Streptomyces & Micromonospora • Broad-spectrum, inhibit protein synthesis, especially useful against aerobic gram-negative rods & certain gram-positive bacteria – Streptomycin – bubonic plague, tularemia, TB – Gentamicin – less toxic, used against gram-negative rods – Newer – Tobramycin & amikacin gram-negative bacteria
  • 29. 29 Tetracycline antibiotics • Broad-spectrum, block protein synthesis • Doxycycline & minocycline – oral drugs taken for STDs, Rocky Mountain spotted fever, Lyme disease, typhus, acne & protozoa
  • 30. 30 Chloramphenicol • Isolated from Streptomyces venezuelae • Potent broad-spectrum drug with unique nitrobenzene structure • Blocks peptide bond formation • No longer derived from natural source • Very toxic, restricted uses, can cause irreversible damage to bone marrow • Typhoid fever, brain abscesses, rickettsial & chlamydial infections
  • 31. 31
  • 32. 32 Other Streptomyces antibiotics • Erythromycin – macrolide, large lactone ring with sugars • Broad-spectrum, fairly low toxicity • Attaches to ribosome • Taken orally for Mycoplasma pneumonia, legionellosis, Chlamydia, pertussis, diptheria and as a prophylactic prior to intestinal surgery • For penicillin-resistant – gonococci, syphilis, acne • Newer semi-synthetic macrolides – clarithomycin, azithromycin
  • 33. 33 Other Streptomyces antibiotics • Clindamycin – broad-spectrum, serious abdominal anaerobic infections • Vancomycin –narrow-spectrum, effective against penicillin & methicillin resistant staphylococcal infections; very toxic, hard to administer • Rifampin – limited spectrum, cannot pause through many cell membranes, used to treat gram-positive bacteria, TB, leprosy
  • 34. 34 The Bacillus antibiotics • Bacitracin- narrow-spectrum peptide produce by Bacillus subtilis, major ingredient of neosporin ointment • Polymyxin - narrow-spectrum peptide with fatty acid component, detergent activity; limited by toxicity to kidney; drug resistant Pseudomonas aeruginosa & UTI
  • 35. 35 New classes of antibiotics • Fosfomycin trimethamine – a phosporic acid effective as alternate treatment for UTIs, inhibits cell wall synthesis • Synercid – effective against Staphylococcus & Enterococcus that cause endocarditis & surgical infections; inhibits protein synthesis
  • 36. 36 Synthetic antibacterial drugs • Sulfonamides, sulfa drugs – first antimicrobic drugs • Sulfisoxazole – shigellosis, UTI, protozoan infections • Silver sulfadiazine –burns, eye infections • Trimethoprim – given in combination with sulfamethoxazole – UTI, PCP
  • 38. 38 Miscellaneous antibacterial drugs • Isoniazid –used with rifampicin to treat TB • Oxazolidinones- new class of antibacterial drugs inhibit initiation of protein synthesis – Linezolid – MRSA, VRE • Fluoroquinolones –broad-spectrum, potent – norfloxacin, ciprofloxacin – UTI, STD, GI, osteomyletitis, respiratory & soft tissue infections – sparofloxacin, levofloxacin – pneumonia, bronchitis, sinusitis
  • 39. 39 Antifungal drugs • Macrolide polyene – Amphotericin B –mimic lipids, most versatile & effective, topical & systemic treatments – Nystatin – topical treatment • Griseofulvin – stubborn cases of dermatophyte infections, nephrotoxic • Synthetic azoles – broad-spectrum; ketoconazole, clotrimazole, miconazole • Flucytosine – analog of cytosine; cutaneous mycoses or in combination with amphotericin B for systemic mycoses
  • 41. 41 Antiparasitic drugs • Antimalarial drugs – quinine, chloroquinine, primaquine, mefloquine • Antiprotozoan drugs - Metronidazole (Flagyl), quinicrine, sulfonamides, tetracyclines • Antihelminthic drugs – immobilize, disintegrate, or inhibit metabolism – mebendazole, thiabendazole- broad-spectrum – inhibit function of microtubules, interfers with glucose utilization & disables them – pyrantel, piperazine- paralyze muscles – niclosamide – destroys scolex
  • 42. 42 Antiviral drugs • Block penetration into host cell • Block transcription or translation – Nucleotide analogs • Acyclovir – herpesviruses • Ribavirin- a guanine analog – RSV, hemorrhagic fevers • AZT – thymine analog - HIV • Prevent maturation of viral particles – Protease inhibitors – HIV • Interferon - HCV
  • 43. 43 Mechanisms drug resistance • Drug inactivation – penicillinases • Decreased permeability to drug or increased elimination of drug from cell • Change in metabolic patterns • Change in drug receptors
  • 45. 45 Selection for drug resistance
  • 46. 46 Side effects of drugs 1. Toxicity to organs 2. Allergic responses 3. Suppression and alteration of microflora
  • 47. 47
  • 48. 48
  • 49. 49 Considerations in selecting an antimicrobial drug 1. nature of microbe causing infection 2. degree of microbe’s sensitivity to various drugs 3. overall medical condition of patient
  • 50. 50 • Minimum inhibitory concentration (MIC)- smallest concentration of drug that visibly inhibits growth • Therapeutic index – the ratio of the dose of the drug that is toxic to humans as compared to its minimum effective dose